The southern US state of Tennessee's TennCare, which adopted Hillary Clinton's 1993 plan for universal health care before escalating costs led to drastic cutbacks in recent years, has reported a more than two-thirds drop in prescription drug spending from 2005 to 2008. In 2005, Governor Phil Bresenden (Democrat) introduced a cap on the number of prescriptions a beneficiary could fill per month to five, of which two could be branded products.
The Chattanooga Times Free Press reports that TennCare's Rx drug spending fell from $2.44 billion to $706.0 million in the three-year period, citing state officials who explained that much of the reduction was attributable to Medicare reforms. However, like-for-like spending still declined 40%, they claimed.
Reflecting the inflated TennCare program before Gov Bresenden was elected on a pledge to control spending, the Novartis Pharmacy Benefit Report found that, in 2008, Tennessee residents still used about 42% more prescription drugs than the US average. The Chattanooga Times cited TennCare's acting pharmacy director, Nicole Woods, who said: "I think we have appropriate safeguards in place to help protect those who may have a legitimate medical need."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze